Yang JC, Chang AE, Baker AR, Sindelar WF, Danforth DN, Topalian SL, et al
Analysts see US focused alcohol companies facing the most exposure from increased obesity medicine usage and expect a roughly 2% drop in consumption by 2035. As for GLP-1 drug users, survey data from the Brightfield Group suggests that a substantial portion are city dwellers with higher incomes that are actively engaged in exercise and diet management, while a recent survey of 2,000 US consumers from direct-to-consumer company Daily Harvest found that GLP-1 drugs were more appealing to those with self-described very healthy diets
Low serum 25-hydroxyvitamin D concentrations in chronic insomnia patients and the association with poor treatment outcome at 2months
Sources: Pennisi M, et al
When that happens, one major risk is that the compounding pharmacy peptide boom will outpace the FDAs ability to monitor them
Sterile Water: This is simply purified water that has been sterilized